Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children
- PMID: 16221511
- DOI: 10.1016/j.vaccine.2005.03.059
Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children
Abstract
Thailand is a canine rabies endemic country with an annual prevalence above 1,000 reported animals diagnosed rabid . Over 345,000 humans are treated for possible rabies exposures annually . Lack of perception of the disease burden, social, cultural and traditional beliefs play an important role in the failure of canine rabies control. It is unfortunate that health care budgets are increasingly allocated to human post-exposure treatment rather than to the eradication of rabies in the canine animal vector. Children under the age of 15 years represent up to one-half of dog bite victims and of human rabies deaths, but accurate data of dog bite prevalence are not available . Large scale pre-exposure immunization of children has been advocated but financial and logistic barriers have hindered implementation. This study analyzes direct medical costs of pre-exposure vaccination (PREP) as a human rabies preventive strategy, against the cost of post-exposure prophylaxis (PEP) in Thai children. Three pre- and post-exposure vaccine regimens are in use and this impacts on cost calculations. It was found that costs of both strategies, PREP of children or PEP of exposed, become equal when the dog bite incidence is 2-30%; depending on which post-exposure treatment regimens (PEP) are used.
Similar articles
-
Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals.Vaccine. 2005 Feb 25;23(14):1709-14. doi: 10.1016/j.vaccine.2004.09.027. Vaccine. 2005. PMID: 15705476 Clinical Trial.
-
Retrospective: animal attacks and rabies exposures in Thai children.Travel Med Infect Dis. 2006 Sep;4(5):270-4. doi: 10.1016/j.tmaid.2005.06.001. Epub 2005 Aug 15. Travel Med Infect Dis. 2006. PMID: 16905457
-
Human rabies post exposure prophylaxis in Bhutan, 2005-2008: trends and risk factors.Vaccine. 2011 May 31;29(24):4094-101. doi: 10.1016/j.vaccine.2011.03.106. Epub 2011 Apr 15. Vaccine. 2011. PMID: 21497633
-
Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV).Hum Vaccin Immunother. 2013 Jul;9(7):1454-9. doi: 10.4161/hv.24502. Epub 2013 Apr 9. Hum Vaccin Immunother. 2013. PMID: 23571224 Review.
-
Moving towards the elimination of rabies in Thailand.J Med Assoc Thai. 2008 Mar;91(3):433-7. J Med Assoc Thai. 2008. PMID: 18575301 Review.
Cited by
-
Costs of rabies control: an economic calculation method applied to Flores Island.PLoS One. 2013 Dec 27;8(12):e83654. doi: 10.1371/journal.pone.0083654. eCollection 2013. PLoS One. 2013. PMID: 24386244 Free PMC article.
-
Development in Immunoprophylaxis against Rabies for Animals and Humans.Avicenna J Med Biotechnol. 2010 Jan;2(1):3-21. Avicenna J Med Biotechnol. 2010. PMID: 23407587 Free PMC article.
-
Development of mRNA rabies vaccines.Hum Vaccin Immunother. 2024 Dec 31;20(1):2382499. doi: 10.1080/21645515.2024.2382499. Epub 2024 Jul 28. Hum Vaccin Immunother. 2024. PMID: 39069645 Free PMC article. Review.
-
Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries.PLoS Negl Trop Dis. 2011 Mar 8;5(3):e982. doi: 10.1371/journal.pntd.0000982. PLoS Negl Trop Dis. 2011. PMID: 21408121 Free PMC article.
-
A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C.PLoS Negl Trop Dis. 2020 Jul 15;14(7):e0008459. doi: 10.1371/journal.pntd.0008459. eCollection 2020 Jul. PLoS Negl Trop Dis. 2020. PMID: 32667913 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
